Cetera Investment Advisers »

Bridgebio Pharma shares owned by Cetera Investment Advisers

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Cetera Investment Advisers from 13F filings

Historical chart of Cetera Investment Advisers investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Cetera Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Cetera Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.6M 73k 76.49
2025-09-30 $3.9M 75k 51.94
2025-06-30 $3.6M 83k 43.18
2025-03-31 $1.8M 52k 34.57
2024-12-31 $1.0M 37k 27.44

More positions owned by Cetera Investment Advisers

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Cetera Investment Advisers

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma